Article(id=1236331824423694650, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236331822909550881, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1696867200000, acceptedDateStr=2023-10-10, onlineDate=1772694076877, onlineDateStr=2026-03-05, pubDate=1701273600000, pubDateStr=2023-11-30, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1772694076877, onlineIssueDateStr=2026-03-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1772694076877, creator=13701087609, updateTime=1772694076877, updator=13701087609, issue=Issue{id=1236331822909550881, tenantId=1146029695717560320, journalId=1235980733773295621, year='2023', volume='32', issue='22', pageStart='2225', pageEnd='2328', issueExtLink='null', onlineDate='null', pubDate='null', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1772694076516, creator=13701087609, updateTime=1772696919965, updator=13701087609, preIssue=null, nextIssue=null, ext={EN=IssueExt(id=1236343749253591892, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236331822909550881, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1236343749253591893, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1236331822909550881, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null}, startPage=2240, endPage=2245, ext={EN=ArticleExt(id=1236331824696324425, articleId=1236331824423694650, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=An overview of phosphodiesterase 4 inhibitors in the treatment of rheumatic autoimmune diseases, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=
Objective:

To review the application and recent research progress of phosphodiesterase 4 (PDE4) inhibitors in rheumatic autoimmune diseases.

Methods:

Through a review of recent relevant literature and guidelines, we explored the latest research progress of PDE4 inhibitors in rheumatic autoimmune diseases such as psoriatic arthritis, Behçet's syndrome, rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, and systemic sclerosis, focusing on their clinical efficacy, safety, and mechanisms of action.

Results:

PDE4 inhibitors demonstrated significant clinical efficacy in rheumatic autoimmune diseases, often accompanied by manageable adverse reactions like nausea and diarrhea.

Conclusion:

PDE4 inhibitors are safe and effective drugs for treating rheumatic autoimmune illnesses and can improve the quality of life. They hold promising prospects for clinical applications.

, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, authorCompany=null, fund=null, authors=null, authorsList=Ye-ling LIU, Wen-jie ZHENG), CN=ArticleExt(id=1236331824989925719, articleId=1236331824423694650, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=磷酸二酯酶4抑制剂在风湿免疫性疾病治疗中的应用, columnId=1236331823664525604, journalTitle=中国新药杂志, columnName=风湿免疫疾病药物治疗专题, runingTitle=null, highlight=null, articleAbstract=
目的:

综述磷酸二酯酶4(phosphodiesterase 4, PDE4)抑制剂在风湿免疫性疾病中的应用及其最新研究进展。

方法:

通过对近年来的相关文献和指南进行综述,探讨PDE4抑制剂在风湿免疫性疾病如银屑病关节炎、白塞综合征、类风湿关节炎、系统性红斑狼疮、强直性脊柱炎、系统性硬化症的临床疗效、安全性以及作用机制等方面的研究进展。

结果:

PDE4抑制剂在风湿免疫性疾病中具有显著的临床疗效,常伴随可耐受的恶心、腹泻等不良反应。

结论:

PDE4抑制剂是一类安全、有效的药物,在控制风湿免疫性疾病病情和改善生活质量方面发挥了重要作用,具有良好的临床应用前景。

, correspAuthors=null, authorNote=null, correspAuthorsNote=
郑文洁,女,教授,博士生导师,研究方向:风湿免疫性疾病机制研究。E-mail:
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=ci78n9joclfyvGR04tVkvw==, magXml=6Nh5ZICDxvlCivimqvIkHg==, pdfUrl=null, pdf=AgXShueOcCeWGe/KHuQfUQ==, pdfFileSize=1241010, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=J+FJa9c/W9bYVXMKJvConA==, mapNumber=null, authorCompany=null, fund=null, authors=

刘烨玲,女,博士研究生,研究方向:风湿免疫性疾病机制研究。E-mail:

, authorsList=刘烨玲, 郑文洁)}, authors=[Author(id=1236331825287721325, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=ylliu@student.pumc.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236331825396773239, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, authorId=1236331825287721325, language=EN, stringName=Ye-ling LIU, firstName=Ye-ling, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology, Ministry of Education, State Key Laboratory of Difficult Severe and Rare Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing 100730, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236331825484853629, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, authorId=1236331825287721325, language=CN, stringName=刘烨玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医学科学院北京协和医学院北京协和医院风湿免疫科,风湿免疫病学教育部重点实验室,疑难重症及罕见病国家重点实验室,国家皮肤与免疫疾病临床医学研究中心,北京 100730, bio={"content":"

刘烨玲,女,博士研究生,研究方向:风湿免疫性疾病机制研究。E-mail:

"}, bioImg=null, bioContent=

刘烨玲,女,博士研究生,研究方向:风湿免疫性疾病机制研究。E-mail:

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236331825187058021, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, xref=null, ext=[AuthorCompanyExt(id=1236331825195446630, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, companyId=1236331825187058021, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology, Ministry of Education, State Key Laboratory of Difficult Severe and Rare Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing 100730, China), AuthorCompanyExt(id=1236331825203835239, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, companyId=1236331825187058021, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医学科学院北京协和医学院北京协和医院风湿免疫科,风湿免疫病学教育部重点实验室,疑难重症及罕见病国家重点实验室,国家皮肤与免疫疾病临床医学研究中心,北京 100730)])]), Author(id=1236331825581322629, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhengwj@pumch.cn, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1236331825669403024, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, authorId=1236331825581322629, language=EN, stringName=Wen-jie ZHENG, firstName=Wen-jie, middleName=null, lastName=ZHENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology, Ministry of Education, State Key Laboratory of Difficult Severe and Rare Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing 100730, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1236331825791037853, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, authorId=1236331825581322629, language=CN, stringName=郑文洁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医学科学院北京协和医学院北京协和医院风湿免疫科,风湿免疫病学教育部重点实验室,疑难重症及罕见病国家重点实验室,国家皮肤与免疫疾病临床医学研究中心,北京 100730, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1236331825187058021, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, xref=null, ext=[AuthorCompanyExt(id=1236331825195446630, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, companyId=1236331825187058021, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology, Ministry of Education, State Key Laboratory of Difficult Severe and Rare Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing 100730, China), AuthorCompanyExt(id=1236331825203835239, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, companyId=1236331825187058021, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医学科学院北京协和医学院北京协和医院风湿免疫科,风湿免疫病学教育部重点实验室,疑难重症及罕见病国家重点实验室,国家皮肤与免疫疾病临床医学研究中心,北京 100730)])])], keywords=[Keyword(id=1236331825929449896, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, language=EN, orderNo=1, keyword=phosphodiesterase 4 inhibitors), Keyword(id=1236331826004947371, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, language=EN, orderNo=2, keyword=rheumatic autoimmune diseases), Keyword(id=1236331826101416373, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, language=EN, orderNo=3, keyword=mechanism), Keyword(id=1236331826181108158, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, language=EN, orderNo=4, keyword=efficacy), Keyword(id=1236331826285965766, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, language=EN, orderNo=5, keyword=safety), Keyword(id=1236331826378240462, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, language=CN, orderNo=1, keyword=磷酸二酯酶4抑制剂), Keyword(id=1236331826466320849, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, language=CN, orderNo=2, keyword=风湿免疫性疾病), Keyword(id=1236331826537624023, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, language=CN, orderNo=3, keyword=作用机制), Keyword(id=1236331826642481632, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, language=CN, orderNo=4, keyword=疗效), Keyword(id=1236331826726367713, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, language=CN, orderNo=5, keyword=安全性)], refs=null, funds=[Fund(id=1236331826864779756, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, awardId=82171800, language=CN, fundingSource=国家自然科学基金资助项目(82171800), fundOrder=null, country=null), Fund(id=1236331826957054447, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, awardId=2022-PUMCH-C-008, language=CN, fundingSource=中央高水平医院临床科研专项(2022-PUMCH-C-008), fundOrder=null, country=null), Fund(id=1236331827053523441, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, awardId=7232124, language=CN, fundingSource=北京市自然科学基金资助项目(7232124), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1236331825187058021, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, xref=null, ext=[AuthorCompanyExt(id=1236331825195446630, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, companyId=1236331825187058021, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology, Ministry of Education, State Key Laboratory of Difficult Severe and Rare Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing 100730, China), AuthorCompanyExt(id=1236331825203835239, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1236331824423694650, companyId=1236331825187058021, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医学科学院北京协和医学院北京协和医院风湿免疫科,风湿免疫病学教育部重点实验室,疑难重症及罕见病国家重点实验室,国家皮肤与免疫疾病临床医学研究中心,北京 100730)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1772610649152, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=C, firstLetterEn=C, subjectCode=Life Sciences, subjectName=null, subjectCodeEn=Life Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1235981903275290962, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1772610649174, updatedTime=1772610649174, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1235981903338205523, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1772610649189, updatedTime=1772610649189, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=C, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2023/V32/I22/2240, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2023/V32/I22/2240, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2023/V32/I22/2240, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2023/V32/I22/2240, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, reference=null)
收藏切换
磷酸二酯酶4抑制剂在风湿免疫性疾病治疗中的应用
收藏切换
PDF下载
刘烨玲 , 郑文洁
中国新药杂志 | 风湿免疫疾病药物治疗专题 2023,32(22): 2240-2245
收起
收藏切换
中国新药杂志 | 风湿免疫疾病药物治疗专题 2023, 32(22): 2240-2245
磷酸二酯酶4抑制剂在风湿免疫性疾病治疗中的应用
全屏
刘烨玲 , 郑文洁
作者信息
  • 中国医学科学院北京协和医学院北京协和医院风湿免疫科,风湿免疫病学教育部重点实验室,疑难重症及罕见病国家重点实验室,国家皮肤与免疫疾病临床医学研究中心,北京 100730
  • 刘烨玲,女,博士研究生,研究方向:风湿免疫性疾病机制研究。E-mail:

通讯作者:

郑文洁,女,教授,博士生导师,研究方向:风湿免疫性疾病机制研究。E-mail:
An overview of phosphodiesterase 4 inhibitors in the treatment of rheumatic autoimmune diseases
Ye-ling LIU , Wen-jie ZHENG
Affiliations
  • Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Rheumatology, Ministry of Education, State Key Laboratory of Difficult Severe and Rare Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing 100730, China
出版时间: 2023-11-30
文章导航
收藏切换
目的:

综述磷酸二酯酶4(phosphodiesterase 4, PDE4)抑制剂在风湿免疫性疾病中的应用及其最新研究进展。

方法:

通过对近年来的相关文献和指南进行综述,探讨PDE4抑制剂在风湿免疫性疾病如银屑病关节炎、白塞综合征、类风湿关节炎、系统性红斑狼疮、强直性脊柱炎、系统性硬化症的临床疗效、安全性以及作用机制等方面的研究进展。

结果:

PDE4抑制剂在风湿免疫性疾病中具有显著的临床疗效,常伴随可耐受的恶心、腹泻等不良反应。

结论:

PDE4抑制剂是一类安全、有效的药物,在控制风湿免疫性疾病病情和改善生活质量方面发挥了重要作用,具有良好的临床应用前景。

磷酸二酯酶4抑制剂  /  风湿免疫性疾病  /  作用机制  /  疗效  /  安全性
Objective:

To review the application and recent research progress of phosphodiesterase 4 (PDE4) inhibitors in rheumatic autoimmune diseases.

Methods:

Through a review of recent relevant literature and guidelines, we explored the latest research progress of PDE4 inhibitors in rheumatic autoimmune diseases such as psoriatic arthritis, Behçet's syndrome, rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, and systemic sclerosis, focusing on their clinical efficacy, safety, and mechanisms of action.

Results:

PDE4 inhibitors demonstrated significant clinical efficacy in rheumatic autoimmune diseases, often accompanied by manageable adverse reactions like nausea and diarrhea.

Conclusion:

PDE4 inhibitors are safe and effective drugs for treating rheumatic autoimmune illnesses and can improve the quality of life. They hold promising prospects for clinical applications.

phosphodiesterase 4 inhibitors  /  rheumatic autoimmune diseases  /  mechanism  /  efficacy  /  safety
刘烨玲, 郑文洁. 磷酸二酯酶4抑制剂在风湿免疫性疾病治疗中的应用. 中国新药杂志, 2023 , 32 (22) : 2240 -2245 .
Ye-ling LIU, Wen-jie ZHENG. An overview of phosphodiesterase 4 inhibitors in the treatment of rheumatic autoimmune diseases[J]. Chinese Journal of New Drugs, 2023 , 32 (22) : 2240 -2245 .
  • 国家自然科学基金资助项目(82171800)
  • 中央高水平医院临床科研专项(2022-PUMCH-C-008)
  • 北京市自然科学基金资助项目(7232124)
2023年第32卷第22期
PDF下载
42
10
引用本文
BibTeX
文章信息
  • 首发时间:2026-03-05
  • 出版时间:2023-11-30
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2023-10-10
基金
国家自然科学基金资助项目(82171800)
中央高水平医院临床科研专项(2022-PUMCH-C-008)
北京市自然科学基金资助项目(7232124)
作者信息
    中国医学科学院北京协和医学院北京协和医院风湿免疫科,风湿免疫病学教育部重点实验室,疑难重症及罕见病国家重点实验室,国家皮肤与免疫疾病临床医学研究中心,北京 100730

通讯作者:

郑文洁,女,教授,博士生导师,研究方向:风湿免疫性疾病机制研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1236331824423694650
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏